Trial Information

Summary: OMEGA-Oral Megadose Corticosteroid Therapy of Acute Exacerbations in Multiple Sclerosis

A one year research study to compare the treatment differences between a 5 day regimen of intravenous (into the vein) and oral steroids in acute attacks of Multiple Sclerosis (MS). This study is investigational and is not currently approved by the Food and Drug Administration for treatment of MS attacks.
No Compensation Provided

Patient Inclusion/Exclusion Criteria:

Males and Females 18-50
Acute changes in MS present for at least 24 hours and less than one week
Must meet entry criteria

Primary progressive MS
Pregnancy
Use of steroids within one month of current attack

Contact:

Michele Weber, Research Coordinator
Mount Sinai Medical Center
One Gustave L. Levy Place

New York, NY 10029
Telephone: 212-241-4264
Fax: 212-241-9771
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:29 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA